Back to mobile site

Form SCHEDULE 13G/A 60 DEGREES PHARMACEUTICA Filed by: Knight Therapeutics Inc.

May 15, 2026 4:05 PM EDT





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) See item 4 below. This constitutes an exit filing for the Reporting Person.


SCHEDULE 13G



 
Knight Therapeutics Inc.
 
Signature:/s/ Samira Sakhia
Name/Title:Samira Sakhia
Date:05/15/2026


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings

Related Entities

13G